111 related articles for article (PubMed ID: 7950913)
1. Conformational change of p53 protein in growth factor-stimulated human myelogenous leukemia cells.
Zhang W; Deisseroth AB
Leuk Lymphoma; 1994 Jul; 14(3-4):251-5. PubMed ID: 7950913
[TBL] [Abstract][Full Text] [Related]
2. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.
Zhu YM; Bradbury DA; Russell NH
Br J Cancer; 1994 Mar; 69(3):468-72. PubMed ID: 8123475
[TBL] [Abstract][Full Text] [Related]
3. Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation.
Bi S; Barton CM; Lemoine NR; Cross NC; Goldman JM
Exp Hematol; 1994 Jan; 22(1):95-9. PubMed ID: 8282066
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the p53 gene in human acute myelogenous leukemia.
Slingerland JM; Minden MD; Benchimol S
Blood; 1991 Apr; 77(7):1500-7. PubMed ID: 2009369
[TBL] [Abstract][Full Text] [Related]
5. p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells.
Zheng A; Mäntymaa P; Säily M; Savolainen E; Vähäkangas K; Koistinen P
Acta Haematol; 2000; 103(3):135-43. PubMed ID: 10940651
[TBL] [Abstract][Full Text] [Related]
6. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells.
Kojima K; Konopleva M; Samudio IJ; Ruvolo V; Andreeff M
Cancer Res; 2007 Apr; 67(7):3210-9. PubMed ID: 17409429
[TBL] [Abstract][Full Text] [Related]
8. Suppression of p53-mediated growth factor withdrawal-induced apoptosis in the myeloid compartment by hematopoietic cytokines: an overview of hematopoiesis and apoptosis with a presentation of thrombopoietin and the M07E cell line as a model system.
Ritchie A; Broxmeyer HE
Crit Rev Oncol Hematol; 1999 Aug; 31(3):169-91. PubMed ID: 10532194
[TBL] [Abstract][Full Text] [Related]
9. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells.
Zhang W; Hu G; Estey E; Hester J; Deisseroth A
Oncogene; 1992 Aug; 7(8):1645-7. PubMed ID: 1630824
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
11. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
[TBL] [Abstract][Full Text] [Related]
12. The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells.
Nishida Y; Maeda A; Kim MJ; Cao L; Kubota Y; Ishizawa J; AlRawi A; Kato Y; Iwama A; Fujisawa M; Matsue K; Weetall M; Dumble M; Andreeff M; Davis TW; Branstrom A; Kimura S; Kojima K
Blood Cancer J; 2017 Feb; 7(2):e527. PubMed ID: 28211885
[TBL] [Abstract][Full Text] [Related]
13. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
[TBL] [Abstract][Full Text] [Related]
14. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia.
Tian WL; Guo R; Wang F; Jiang ZX; Tang P; Huang YM; Sun L
Exp Cell Res; 2018 Apr; 365(2):185-193. PubMed ID: 29501566
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
16. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
[TBL] [Abstract][Full Text] [Related]
17. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
Zhu YM; Bradbury D; Russell N
Br J Cancer; 1993 Nov; 68(5):851-5. PubMed ID: 8217600
[TBL] [Abstract][Full Text] [Related]
18. Germ-line-derived hinge domain p53 mutants have lost apoptotic but not cell cycle arrest functions.
Aurelio ON; Cajot JF; Hua ML; Khwaja Z; Stanbridge EJ
Cancer Res; 1998 May; 58(10):2190-5. PubMed ID: 9605765
[TBL] [Abstract][Full Text] [Related]
19. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
Geley S; Hartmann BL; Hattmannstorfer R; Löffler M; Ausserlechner MJ; Bernhard D; Sgonc R; Strasser-Wozak EM; Ebner M; Auer B; Kofler R
Oncogene; 1997 Nov; 15(20):2429-37. PubMed ID: 9395239
[TBL] [Abstract][Full Text] [Related]
20. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.
Bykov VJ; Issaeva N; Shilov A; Hultcrantz M; Pugacheva E; Chumakov P; Bergman J; Wiman KG; Selivanova G
Nat Med; 2002 Mar; 8(3):282-8. PubMed ID: 11875500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
